Search by Drug Name or NDC
NDC 69536-0250-24 Bronkaid 25 mg/1 Details
Bronkaid 25 mg/1
Bronkaid is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Foundation Consumer Healthcare LLC. The primary component is EPHEDRINE SULFATE.
Product Information
| NDC | 69536-0250 |
|---|---|
| Product ID | 69536-250_8aa556d0-811e-4958-8a63-daca8bfdf676 |
| Associated GPIs | 44202010100335 |
| GCN Sequence Number | 005061 |
| GCN Sequence Number Description | ephedrine sulfate TABLET 25 MG ORAL |
| HIC3 | J5E |
| HIC3 Description | SYMPATHOMIMETIC AGENTS |
| GCN | 20221 |
| HICL Sequence Number | 002084 |
| HICL Sequence Number Description | EPHEDRINE SULFATE |
| Brand/Generic | Brand |
| Proprietary Name | Bronkaid |
| Proprietary Name Suffix | Max |
| Non-Proprietary Name | EPHEDRINE SULFATE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | EPHEDRINE SULFATE |
| Labeler Name | Foundation Consumer Healthcare LLC |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2022-12-31 |
Package
Package Images
NDC 69536-0250-24 (69536025024)
| NDC Package Code | 69536-250-24 |
|---|---|
| Billing NDC | 69536025024 |
| Package | 4 BLISTER PACK in 1 CARTON (69536-250-24) / 6 TABLET, COATED in 1 BLISTER PACK |
| Marketing Start Date | 2020-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 9a0b792a-caee-41f6-9400-922a5ebd592f Details
Uses
Warnings
Asthma alert
Because asthma may be life threatening, see a doctor if you
- are not better in 60 minutes
- get worse
- need more than 6 caplets in 24 hours
- use more than 4 caplets in 24 hours for 3 or more days a week
- have more than 2 asthma attacks in a week
These may be signs that your asthma is getting worse.
- This product will not give you asthma relief as quickly as an inhaled bronchodilator.
Do not use
- unless a doctor said you have asthma
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
- if you have ever had an allergic reaction to this product or any of its ingredients
Ask a doctor before use if you have
- ever been hospitalized for asthma
- heart disease
- high blood pressure
- diabetes
- thyroid disease
- seizures
- narrow angle glaucoma
- a psychiatric or emotional condition
- trouble urinating due to an enlarged prostate gland
Ask a doctor or pharmacist before use if you are
- taking prescription drugs for asthma, obesity, weight control, depression, or psychiatric or emotional conditions
- taking any drug that contains phenylephrine, pseudoephedrine, ephedrine, or caffeine (such as for allergy, cough-cold, or pain)
When using this product
- your blood pressure or heart rate may go up. This could increase your risk of heart attack or stroke, which may cause death.
-
your risk of heart attack or stroke increases if you:
- have a history of high blood pressure or heart disease
- take this product more frequently or take more than the recommended dose
- avoid foods or beverages that contain caffeine
- avoid dietary supplements containing ingredients reported or claimed to have a stimulant effect
Directions
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 24 Caplet Blister Pack Carton
INGREDIENTS AND APPEARANCE
| BRONKAID
MAX
ephedrine sulfate tablet, coated |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - Foundation Consumer Healthcare LLC (079675882) |
Revised: 6/2020
Document Id: 8aa556d0-811e-4958-8a63-daca8bfdf676
Set id: 9a0b792a-caee-41f6-9400-922a5ebd592f
Version: 1
Effective Time: 20200611